Why the study?
Does the combination of higenamine and [6]-gingerol prevent doxorubicin-induced cytotoxicity in in vitro cardiomyocyte models?
Population
in vitro neonatal rat cardiomyocytes and H9c2 cell line models of doxorubicin-induced cytotoxicity
Comparison
Higenamine combined with [6]-gingerol vs Single agents, dexrazoxane, or doxorubicin alone
Design
Preclinical
Authors
Loading...
May protect cardiomyocytes from doxorubicin in vitro; hypothesis-generating and requires in vivo and clinical validation before any practice change.
Does the combination of higenamine and [6]-gingerol prevent doxorubicin-induced cytotoxicity in in vitro cardiomyocyte models?
The combination of higenamine and [6]-gingerol protects against doxorubicin-induced cardiotoxicity in vitro by activating the PI3K/Akt signaling pathway, suggesting they may be the active cardioprotective components of Sini decoction.
Chen et al. (2013) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: